A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Abstract Developing therapeutics against SARS-CoV-2 could be guided by the distribution of epitopes, not only on the receptor binding domain (RBD) of the Spike (S) protein, but also across the full Spike (S) protein. We isolated and characterized monoclonal […]

Click here to view original web page at A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses

1 Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States 2 Curriculum in Genetics and Molecular Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States 3 Department […]

Click here to view original web page at The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses